{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:43Z","timestamp":1791314383000,"version":"4.3.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1673-5374.182682","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T01:00:34Z","timestamp":1464829234000},"page":"702","source":"Crossref","is-referenced-by-count":38,"title":["Clinical trial perspective for adult and juvenile Huntington\u2032s disease using genetically-engineered mesenchymal stem cells"],"prefix":"10.4103","volume":"11","author":[{"given":"KyleD","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Torrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Dahlenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Annett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JanA","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.182682-1","doi-asserted-by":"crossref","unstructured":"Aylward EH (2007) Change in MRI striatal volumes as a biomarker in preclinical Huntington\u2032s disease. Brain Res Bull 72:152-158.","DOI":"10.1016\/j.brainresbull.2006.10.028"},{"key":"key-10.4103\/1673-5374.182682-2","doi-asserted-by":"crossref","unstructured":"Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA (2012) Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF. Gene Ther 19:483-493.","DOI":"10.1038\/gt.2011.114"},{"key":"key-10.4103\/1673-5374.182682-3","doi-asserted-by":"crossref","unstructured":"Chen C, Uluda\u00f0 H, Wang Z, Jiang H (2012) Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro. J Cell Biochem 113:3672-3680.","DOI":"10.1002\/jcb.24240"},{"key":"key-10.4103\/1673-5374.182682-4","doi-asserted-by":"crossref","unstructured":"Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V (2007) Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2032s disease patients. Am J Med Genet B Neuropsychiatr Genet 144B:574-577.","DOI":"10.1002\/ajmg.b.30501"},{"key":"key-10.4103\/1673-5374.182682-5","doi-asserted-by":"crossref","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2032s disease. Behav Brain Res 214:193-200.","DOI":"10.1016\/j.bbr.2010.05.023"},{"key":"key-10.4103\/1673-5374.182682-6","doi-asserted-by":"crossref","unstructured":"Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS (2003) BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 44 Suppl 1:305-131.","DOI":"10.1080\/03008200390181825"},{"key":"key-10.4103\/1673-5374.182682-7","doi-asserted-by":"crossref","unstructured":"Fibbe WE, Dazzi F, LeBlanc K (2013) MSCs: science and trials. Nat Med 19:812-813.","DOI":"10.1038\/nm.3222"},{"key":"key-10.4103\/1673-5374.182682-8","doi-asserted-by":"crossref","unstructured":"Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA (2015) Developing stem cell therapies for juvenile and adult-onset Huntington\u2032s disease. Regen Med 10:623-646.","DOI":"10.2217\/rme.15.25"},{"key":"key-10.4103\/1673-5374.182682-9","doi-asserted-by":"crossref","unstructured":"Gonzalez-Alegre P, Afifi AK (2006) Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature. J Child Neurol 21:223-229.","DOI":"10.2310\/7010.2006.00055"},{"key":"key-10.4103\/1673-5374.182682-10","doi-asserted-by":"crossref","unstructured":"Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.","DOI":"10.1146\/annurev.biochem.72.121801.161629"},{"key":"key-10.4103\/1673-5374.182682-11","doi-asserted-by":"crossref","unstructured":"Isakova IA, Lanclos C, Bruhn J, Kuroda MJ, Baker KC, Krishnappa V, Phinney DG (2014) Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo. PLoS One 9:e87238.","DOI":"10.1371\/journal.pone.0087238"},{"key":"key-10.4103\/1673-5374.182682-12","doi-asserted-by":"crossref","unstructured":"Jacobsen JC, Bawden CS, Rudiger SR, McLaughlan CJ, Reid SJ, Waldvogel HJ, MacDonald ME, Gusella JF, Walker SK, Kelly JM, Webb GC, Faull RL, Rees MI, Snell RG (2010) An ovine transgenic Huntington\u2032s disease model. Hum Mol Genet 19:1873-1882.","DOI":"10.1093\/hmg\/ddq063"},{"key":"key-10.4103\/1673-5374.182682-13","doi-asserted-by":"crossref","unstructured":"Kordower JH (2016) AAV2-neurturin for Parkinson\u2032s disease: what lessons have we learned? Methods Mol Biol 1382:485-490.","DOI":"10.1007\/978-1-4939-3271-9_32"},{"key":"key-10.4103\/1673-5374.182682-14","doi-asserted-by":"crossref","unstructured":"Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA (2010) Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 62:1167-1174.","DOI":"10.1016\/j.addr.2010.09.013"},{"key":"key-10.4103\/1673-5374.182682-15","doi-asserted-by":"crossref","unstructured":"Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D (2016) Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: Results of phase 1\/2 and 2a clinical trials. JAMA Neurol 73:337-344.","DOI":"10.1001\/jamaneurol.2015.4321"},{"key":"key-10.4103\/1673-5374.182682-16","doi-asserted-by":"crossref","unstructured":"Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, et al. (2016) Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington\u2032s disease mouse models. Mol Ther doi:10.1038\/mt.2016.12.","DOI":"10.1038\/mt.2016.12"},{"key":"key-10.4103\/1673-5374.182682-17","unstructured":"Robertson L, Santini H, O\u2032Donovan KL, Squitieri F, Barker RA, Rakowicz M, Landwehrmeyer GB, Quarrell O (2012) Current pharmacological management in juvenile Huntington\u2032s disease. PLoS Curr 4:RRN1304."},{"key":"key-10.4103\/1673-5374.182682-18","doi-asserted-by":"crossref","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204-216.","DOI":"10.1038\/nrneurol.2014.24"},{"key":"key-10.4103\/1673-5374.182682-19","doi-asserted-by":"crossref","unstructured":"Scharfman HE (2005) Brain-derived neurotrophic factor and epilepsy--a missing link? Epilepsy Curr 5:83-88.","DOI":"10.1111\/j.1535-7511.2005.05312.x"},{"key":"key-10.4103\/1673-5374.182682-20","doi-asserted-by":"crossref","unstructured":"The Huntington\u2032s Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2032s disease chromosomes. The Huntington\u2032s Disease Collaborative Research Group. Cell 72:971-983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"key-10.4103\/1673-5374.182682-21","doi-asserted-by":"crossref","unstructured":"Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-L\u00e8vi AC, Tabrizi SJ, Di Donato S, Cattaneo E (2011) Brain-derived neurotrophic factor in patients with Huntington\u2032s disease. PLoS One 6:e22966.","DOI":"10.1371\/journal.pone.0022966"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:07Z","timestamp":1786714387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.182682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["182682"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.182682","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}